Pediatric asthma and COVID-19: The known, the unknown, and the controversial

Pediatr Pulmonol. 2020 Dec;55(12):3573-3578. doi: 10.1002/ppul.25117. Epub 2020 Oct 22.

Abstract

The novel coronavirus disease-2019 (COVID-19), caused by the pathogen severe acute respiratory syndrome-CoV-2, is causing a global pandemic, with over 26.9 million cases and 880,000 deaths as of September 6, 2020. While there has been speculation and observational research about the impact of COVID-19 on asthma, much remains unknown. The goal of this article is to provide a scoping review on pediatric asthma and COVID-19 and summarize what we do and do not know from the first wave of the pandemic.

Keywords: COVID-19; asthma; pediatrics; social determinants of health.

Publication types

  • Review

MeSH terms

  • Asthma / diagnosis*
  • Asthma / epidemiology
  • Asthma / therapy*
  • Betacoronavirus
  • COVID-19
  • Child
  • Communicable Disease Control
  • Comorbidity
  • Coronavirus
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / epidemiology*
  • Delivery of Health Care*
  • Diagnosis, Differential
  • Disease Management
  • Environmental Exposure*
  • Humans
  • Masks*
  • Pandemics
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / epidemiology*
  • SARS-CoV-2
  • Social Determinants of Health*
  • Spirometry
  • Tobacco Smoke Pollution

Substances

  • Tobacco Smoke Pollution